Industry Focus
Healthcare: Are These Beaten-Down Clinical-Stage Biotechs Buys?
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:31:01
- Mais informações
Informações:
Sinopse
Geron shares tumbled after J&J jilted them and Omeros shares fell sharply following a clinical-trial update. Should you avoid these stocks, or are they bargain bin stocks worth buying? GERN OMER INCY
